Targeted Expansion Growing international footprint with representation in over 40 countries presents multiple cross-border sales opportunities for NPi pupillometry devices, service contracts, and training partnerships.

Clinical Education Recent Pupillometry Education Symposiums platform indicates demand for clinician training; potential upsell of education bundles, on-site workshops, and certification programs to hospitals and academic centers.

Product Innovation Launch of NPi-300 demonstrates advanced automated pupillometry capabilities; explore refresh cycles, integration with existing patient monitoring systems, and expanded clinical use cases to capture larger purchase orders.

Health Outcomes Clear focus on neurological assessment and critical care aligns with hospital initiatives to improve patient outcomes; position NeurOptics as a key partner for critical care teams and neurology departments seeking objective pupillometry metrics.

SMB Growth Mid-sized company profile with moderate revenue and global reach; target mid to large health systems and specialty clinics seeking scalable solutions, multi-site deployments, and managed services at a favorable price-to-value ratio.